SHANTHI BALARAMAN: Open Payments
NPI 1558818856 · HOCKESSIN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 12 payments from 5 companies in 2025. Trend: 2023 $294 · 2024 $157 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $98 |
| Lilly USA, LLC | 3 | $58 |
| Novo Nordisk Inc | 2 | $38 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: QULIPTA, MOUNJARO, Rybelsus, UBRELVY, NURTEC ODT, TRELEGY ELLIPTA.
Industry payments across DE — which companies pay providers there.
